SPONSOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Total Trials
3
Recruiting
3
Phases
Phase 4
Conditions studied: FSHD1FSHD2Cancer-associated ThrombosisVenous ThromboembolismGynecologic CancerOvarian CancerCervix CancerEndometrial CancerVaginal CancerBladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including FSHD1, FSHD2, Cancer-associated Thrombosis, Venous Thromboembolism.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
How many clinical trials has Fondazione Policlinico Universitario Agostino Gemelli IRCCS sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, of which 3 are actively recruiting participants. These trials cover conditions including FSHD1, FSHD2, Cancer-associated Thrombosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fondazione Policlinico Universitario Agostino Gemelli IRCCS research focus on?
Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trials span FSHD1, FSHD2, Cancer-associated Thrombosis, Venous Thromboembolism, Gynecologic Cancer, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trial?
To participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials with current recruitment status updated daily.
Clinical Trials by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT06078852
Recruiting
Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients
FSHD1
NCT06284343
Recruiting
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Cancer-associated Thrombosis
NCT06820255 Phase 4
Recruiting
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology